Resvita Bio Advance RVB-003 For IND Filling in Netherton Syndrome
24 Sep 2025 //
PR NEWSWIRE
ResVita Bio`s RVB-003 gets Orphan Designation for Netherton Syndrome
03 Apr 2025 //
PR NEWSWIRE
ResVita Bio Receives NIH Grant to Develop Treatment for Severe Atopic Dermatitis
18 Sep 2023 //
PR NEWSWIRE

Market Place
Sourcing Support